About the poster presentation

EBC will hold a poster presentation at IASP 2024 World Congress on Pain on the topic “Health Gains and Socio-Economic Impacts of Structured Interdisciplinary Management of Fibromyalgia Syndrome“.

Fibromyalgia is one of the largest health burdens in countries around the globe. Pain specialists had developed a multimodal and interdisciplinary approach to chronic pain management in the 1980ies that leads to major improvements in functioning and quality of life and reduced work absenteeism. Structured interdisciplinary pain management is offered by specialized clinics in some countries, but is not generally available to the patient population at large. This is partly due to the consideration that it may be too expensive. Led by the European Brain Council within the Value of Treatment (VoT) initiative, VoT Chronic Pain analysed to what extent the cost of structured interdisciplinary management is offset by savings in direct and indirect cost of continuing the current standard of care.  

The aim of this study is to assess the cost-effectiveness of chronic pain management in a model country (Germany) with and without structured interdisciplinary treatment in patients with fibromyalgia. 

Come and participate in the IASP 2024 World Congress on Pain to delve into the findings of the study and interact with experts face-to-face to ask your questions!

Mark Nuijten

Mark Nuijten, PhD, MD, MBA, is an Adjunct Professor at ITU, a medical doctor, health economist, market access and pricing consultant, valuation economist, and healthcare policy journalist. He has a diverse career in the health academic and business environment, collaborating with leading experts in health economics.

Nuijten is developing economic modelling in healthcare and finance. He’s a pioneer in healthcare innovation in biotechnology and nutrition, and the first to apply and develop Discounted Cash Flow methodologies for biotechnology innovation valuation. His innovative concepts include the Pricing Matrix Model for early phase pricing and the Financial Valuation Algorithm for assessing future cash flows of new medicinal products. His reimbursement dossiers have contributed to positive reimbursement decisions by health authorities in many countries.

He supervises PhD programs at the Universities of Maastricht and Groningen in The Netherlands and is the founder of the ISPOR Special Interest Group on nutrition-economics. He is also an Adjunct Professor at ITU (Istanbul Technical University) in International Healthcare Assessment and Valuation.

Nuijten is a founding member of Minerva Health Economics Network, Ltd. (MINERVA), an affiliation of independent health-economic consultancies and contract-research organizations. Before setting up A2M, he was a partner with EVIDERA, establishing global Pricing and Reimbursement Consultancy Services, and was Managing Director of the IQVIA office in the Netherlands.

Nuijten trained as a physician before obtaining an international MBA from Erasmus University, Rotterdam, and a PhD in health economics. He has become a leading health economic expert, with over 200 publications and leading positions in scientific societies and editorial boards. He was on the Board of Directors of ISPOR (2002-2004) and contributed to the first Dutch pharmaco-economic research guidelines and costing manual.